These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 27376271)

  • 1. Novel NSAID-Derived Drugs for the Potential Treatment of Alzheimer's Disease.
    Cacciatore I; Marinelli L; Fornasari E; Cerasa LS; Eusepi P; Türkez H; Pomilio C; Reale M; D'Angelo C; Costantini E; Di Stefano A
    Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27376271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of flurbiprofen and chemically related anti-inflammatory drugs in models of Alzheimer's disease.
    Gasparini L; Ongini E; Wilcock D; Morgan D
    Brain Res Brain Res Rev; 2005 Apr; 48(2):400-8. PubMed ID: 15850679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo profiling of CHF5022 and CHF5074 Two beta-amyloid1-42 lowering agents.
    Imbimbo BP; Del Giudice E; Cenacchi V; Volta R; Villetti G; Facchinetti F; Riccardi B; Puccini P; Moretto N; Grassi F; Ottonello S; Leon A
    Pharmacol Res; 2007 Apr; 55(4):318-28. PubMed ID: 17292621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ibuprofen and glutathione conjugate as a potential therapeutic agent for treating Alzheimer's disease.
    Pinnen F; Sozio P; Cacciatore I; Cornacchia C; Mollica A; Iannitelli A; D'Aurizio E; Cataldi A; Zara S; Nasuti C; Di Stefano A
    Arch Pharm (Weinheim); 2011 Mar; 344(3):139-48. PubMed ID: 21384412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Memantine-sulfur containing antioxidant conjugates as potential prodrugs to improve the treatment of Alzheimer's disease.
    Sozio P; Cerasa LS; Laserra S; Cacciatore I; Cornacchia C; Di Filippo ES; Fulle S; Fontana A; Di Crescenzo A; Grilli M; Marchi M; Di Stefano A
    Eur J Pharm Sci; 2013 May; 49(2):187-98. PubMed ID: 23454012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oligomers of β-amyloid protein (Aβ1-42) induce the activation of cyclooxygenase-2 in astrocytes via an interaction with interleukin-1β, tumour necrosis factor-α, and a nuclear factor κ-B mechanism in the rat brain.
    Carrero I; Gonzalo MR; Martin B; Sanz-Anquela JM; Arévalo-Serrano J; Gonzalo-Ruiz A
    Exp Neurol; 2012 Aug; 236(2):215-27. PubMed ID: 22617488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ibuprofen and lipoic acid diamide as co-drug with neuroprotective activity: pharmacological properties and effects in beta-amyloid (1-40) infused Alzheimer's disease rat model.
    Di Stefano A; Sozio P; Cerasa LS; Iannitelli A; Cataldi A; Zara S; Giorgioni G; Nasuti C
    Int J Immunopathol Pharmacol; 2010; 23(2):589-99. PubMed ID: 20646354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ibuprofen and lipoic acid diamides as potential codrugs with neuroprotective activity.
    Sozio P; D'Aurizio E; Iannitelli A; Cataldi A; Zara S; Cantalamessa F; Nasuti C; Di Stefano A
    Arch Pharm (Weinheim); 2010 Mar; 343(3):133-42. PubMed ID: 20186865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoechinulin A suppresses amyloid-β oligomer-induced microglia activation and thereby protects PC-12 cells from inflammation-mediated toxicity.
    Dewapriya P; Li YX; Himaya SW; Pangestuti R; Kim SK
    Neurotoxicology; 2013 Mar; 35():30-40. PubMed ID: 23261590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NSAIDs and enantiomers of flurbiprofen target gamma-secretase and lower Abeta 42 in vivo.
    Eriksen JL; Sagi SA; Smith TE; Weggen S; Das P; McLendon DC; Ozols VV; Jessing KW; Zavitz KH; Koo EH; Golde TE
    J Clin Invest; 2003 Aug; 112(3):440-9. PubMed ID: 12897211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective effect of Chunghyuldan from amyloid beta oligomer induced neuroinflammation in vitro and in vivo.
    Kim HG; Kim JY; Whang WW; Oh MS
    Can J Physiol Pharmacol; 2014 Jun; 92(6):429-37. PubMed ID: 24820962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer's disease.
    Maczurek A; Hager K; Kenklies M; Sharman M; Martins R; Engel J; Carlson DA; Münch G
    Adv Drug Deliv Rev; 2008; 60(13-14):1463-70. PubMed ID: 18655815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activated human microglia stimulate neuroblastoma cells to upregulate production of beta amyloid protein and tau: implications for Alzheimer's disease pathogenesis.
    Lee M; McGeer E; McGeer PL
    Neurobiol Aging; 2015 Jan; 36(1):42-52. PubMed ID: 25169677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study of curcuminoids to measure their effect on inflammatory and apoptotic gene expression in an Aβ plus ibotenic acid-infused rat model of Alzheimer's disease.
    Ahmed T; Gilani AH
    Brain Res; 2011 Jul; 1400():1-18. PubMed ID: 21640982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel therapeutic opportunities for Alzheimer's disease: focus on nonsteroidal anti-inflammatory drugs.
    Townsend KP; Praticò D
    FASEB J; 2005 Oct; 19(12):1592-601. PubMed ID: 16195368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S- but not R-enantiomers of flurbiprofen and ibuprofen reduce human microglial and THP-1 cell neurotoxicity.
    Klegeris A; Maguire J; McGeer PL
    J Neuroimmunol; 2004 Jul; 152(1-2):73-7. PubMed ID: 15223239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential role of non-steroidal anti-inflammatory drugs in treating Alzheimer's disease.
    Imbimbo BP
    Expert Opin Investig Drugs; 2004 Nov; 13(11):1469-81. PubMed ID: 15500394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and evaluation of 4'-OH-flurbiprofen-chalcone hybrids as potential multifunctional agents for Alzheimer's disease treatment.
    Cao Z; Yang J; Xu R; Song Q; Zhang X; Liu H; Qiang X; Li Y; Tan Z; Deng Y
    Bioorg Med Chem; 2018 Mar; 26(5):1102-1115. PubMed ID: 29409707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploiting the lipoic acid structure in the search for novel multitarget ligands against Alzheimer's disease.
    Rosini M; Simoni E; Bartolini M; Tarozzi A; Matera R; Milelli A; Hrelia P; Andrisano V; Bolognesi ML; Melchiorre C
    Eur J Med Chem; 2011 Nov; 46(11):5435-42. PubMed ID: 21924801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NSAID and antioxidant prevention of Alzheimer's disease: lessons from in vitro and animal models.
    Cole GM; Morihara T; Lim GP; Yang F; Begum A; Frautschy SA
    Ann N Y Acad Sci; 2004 Dec; 1035():68-84. PubMed ID: 15681801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.